Xiaolong Qin

机构：ShanghaiTech University

发表论文 3 篇 · 总被引 25 次 · h-index 1

代表论文

• Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling (2023 · Experimental Hematology and Oncology · 被引 25)
• Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers (2026 · Journal of Advanced Research)
• Index (2020)